Yifeng Pharmacy Chain Co., Ltd.

Equities

603939

CNE100001TS5

Drug Retailers

End-of-day quote Shanghai S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
43.3 CNY -1.28% Intraday chart for Yifeng Pharmacy Chain Co., Ltd. +1.45% +8.14%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Yifeng Pharmacy Chain Lists 1.80 Billion Yuan Worth of Convertible Bonds on Shanghai Bourse MT
Nomura Adjusts Yifeng Pharmacy Chain’s Price Target to 49.56 Yuan From 48.61 Yuan, Keeps at Buy MT
Yifeng Pharmacy Chain Co., Ltd.(SHSE:603939) added to Shanghai Stock Exchange 180 Value Index CI
Yifeng Pharmacy Chain Co., Ltd.(SHSE:603939) added to SSE 180 Index CI
Yifeng Pharmacy Chain Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Nomura Adjusts Yifeng Pharmacy Chain's Price Target to 48.61 Yuan From 50.32 Yuan, Keeps at Buy MT
Yifeng Pharmacy Chain Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Breakfast for 40 cents: what China's deflation looks like RE
Nomura Adjusts Yifeng Pharmacy's Price Target to 50.32 Yuan From 48.99 Yuan, Keeps at Buy MT
Shanghai Bourse Defers Review of Yifeng Pharmacy Chain’s Bond Sale Application MT
Nomura Starts Yifeng Pharmacy Chain at Buy With 68.58 Yuan Price Target MT
Yifeng Pharmacy Chain Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Yifeng Pharmacy Chain to Sell 2.5 Billion Yuan Bonds for Expansion Plans MT
Yifeng Pharmacy Chain Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
UBS Adjusts Yifeng Pharmacy Chain’s Price Target to 65.50 Yuan From 60 Yuan, Keeps at Buy MT
UBS Adjusts Yifeng Pharmacy Chain's Price Target to 65.5 Yuan From 60 Yuan, Keeps at Buy MT
Yifeng Pharmacy Chain Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Beijing Mulls Banning Internet Healthcare Firms From Selling Drugs Online MT
Yifeng Pharmacy Chain Co., Ltd. completed the acquisition of a 51% stake in Hunan Jiuzhitang Pharmaceutical Co., Ltd. from Jiuzhitang Co., Ltd.. CI
UBS Adjusts Yifeng Pharmacy Chain’s Price Target to 60 Yuan From 86 Yuan, Keeps at Buy MT
Yifeng Pharmacy Chain Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Yifeng Pharmacy Chain Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Yifeng Pharmacy Chain Co., Ltd. agreed to acquire 5% stake in Jiuzhitang Co., Ltd. from Li Zhenguo for CNY 430 million. CI
Yifeng Pharmacy Chain Co., Ltd. agreed to acquire 51% of stake in Hunan Jiuzhitang Pharmaceutical Co., Ltd. from Jiuzhitang Co., Ltd. for approximately CNY 200 million. CI
Yifeng Pharmacy Chain Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Chart Yifeng Pharmacy Chain Co., Ltd.
More charts
Yifeng Pharmacy Chain Co Ltd is a China-based company principally engaged in the chain retailing of pharmaceuticals, health products, medical equipment and health-related household convenience products. The Company mainly operates through retailing segment. The Company operates direct pharmaceutical chain stores mainly in provinces (or municipalities), including Hunan, Hubei, Shanghai, Jiangsu, Zhejiang and Jiangxi. The retail products of the Company includes pharmaceuticals, medical equipment, health products, health food, personal care products and maternal and child products. The Company is also engaged in the wholesale business through its subsidiary, Hunan Yifeng Pharmaceutical Co., Ltd.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
43.3 CNY
Average target price
50.92 CNY
Spread / Average Target
+17.60%
Consensus
  1. Stock Market
  2. Equities
  3. 603939 Stock
  4. News Yifeng Pharmacy Chain Co., Ltd.
  5. Yifeng Pharmacy Chain Lists 1.80 Billion Yuan Worth of Convertible Bonds on Shanghai Bourse